CLINICAL EXPERIENCE SINCE APPROVAL
VYNDAMAX® (tafamidis) is the first and only single capsule for transthyretin cardiac amyloidosis (ATTR-CM) taken once a day, every day.
Create a discussion guide to help you log your symptoms and talk to your doctor about ATTR-CM
Find out how VYNDAMAX may help treat ATTR-CM
Watch to learn how VYNDAMAX can impact ATTR-CM
Watch to learn how VYNDAMAX can impact ATTR-CM
Receive educational materials throughout your journey
Get to the heart of what to know about ATTR-CM and VYNDAMAX
Hear from Stan, a real patient currently taking VYNDAMAX